Clinical Trials on Neurofibromatosis 1

Total 6952 results

University of Utah
University of British Columbia; Children's Hospital Medical Center, Cincinnati and other collaborators

Terminated

Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1) (VitDBoneNF1)

Neurofibromatosis Type 1 (NF1)

United States, Canada
University of Alabama at Birmingham

Completed

MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1 (MEK Inhibitor)

Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN

United States
NYU Langone Health
National Institute of Neurological Disorders and Stroke (NINDS)

Not yet recruiting

Gait in Young Children With NF1

Neurofibromatosis Type 1
AstraZeneca

Recruiting

Prevalence, Clinical Characteristics, Progression, and Management of Neurofibromatosis Type 1 in Egypt (NF1-Egy) (PRECIOUS Egypt)

Neurofibromatosis Type 1

Egypt
Pasithea Therapeutics Corp.
Novotech (Australia) Pty Limited

Recruiting

PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas

Neurofibroma, Plexiform | Neurofibroma Plexiform | Neurofibromatosis Type 1 (NF1) | Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs) | NF1 Mutation

Australia, United States, South Korea

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe